Bioceres Crop Solutions Corp.
BIOX · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -2.60 | -0.16 | 14.50 |
| FCF Yield | 12.49% | 2.71% | -2.41% | -4.57% |
| EV / EBITDA | 38.73 | 16.70 | 14.36 | 14.95 |
| Quality | ||||
| ROIC | -0.57% | 4.21% | 8.59% | -3.01% |
| Gross Margin | 39.06% | 39.07% | 42.97% | 38.49% |
| Cash Conversion Ratio | -0.85 | 6.67 | 0.13 | 4.48 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.38% | 12.27% | 26.60% | 23.98% |
| Free Cash Flow Growth | 86.43% | 194.79% | 24.66% | -31.71% |
| Safety | ||||
| Net Debt / EBITDA | 17.95 | 4.08 | 2.89 | 2.84 |
| Interest Coverage | -0.07 | 1.67 | 2.28 | 2.22 |
| Efficiency | ||||
| Inventory Turnover | 2.26 | 2.24 | 1.70 | 1.60 |
| Cash Conversion Cycle | 191.81 | 123.63 | 152.54 | 145.39 |